ICU Medical Inc. (ICUI) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
951 CALLE AMANECER SAN CLEMENTE, CA 92763-6212 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 309 | 255 | 213 | 567 | 411 | 293 | |||
| Cash and cash equivalent | 209 | 553 | 396 | 269 | |||||
| Short-term investments | 1 | 4 | 14 | ||||||
| Other undisclosed cash, cash equivalents, and short-term investments | 309 | 254 | 15 | 24 | |||||
| Receivables | 183 | 162 | 222 | 106 | 124 | 202 | |||
| Inventory, net of allowances, customer advances and progress billings | 585 | 709 | 696 | 290 | 315 | 338 | |||
| Inventory | 585 | 709 | 696 | 290 | 315 | 338 | |||
| Prepaid expense | 27 | 40 | 37 | 34 | 44 | 29 | |||
| Derivative instruments and hedges, assets | 7 | 7 | 5 | 1 | 4 | ||||
| Disposal group, including discontinued operation | 13 | ||||||||
| Other current assets | 5 | 4 | 4 | 2 | 2 | 4 | |||
| Other undisclosed current assets | 314 | 45 | 59 | 29 | 21 | 16 | |||
| Total current assets: | 1,442 | 1,221 | 1,235 | 1,030 | 921 | 882 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 3 | ||||||||
| Operating lease, right-of-use asset | 53 | 70 | 75 | 40 | 47 | 34 | |||
| Property, plant and equipment | 443 | 613 | 636 | 468 | 467 | 456 | |||
| Long-term investments and receivables | 1 | ||||||||
| Long-term investments | 1 | ||||||||
| Intangible assets, net (including goodwill) | 2,174 | 2,343 | 2,432 | 232 | 230 | 243 | |||
| Goodwill | 1,433 | 1,472 | 1,449 | 43 | 33 | 31 | |||
| Intangible assets, net (excluding goodwill) | 741 | 871 | 983 | 188 | 197 | 211 | |||
| Deferred income tax assets | 24 | 37 | 31 | 43 | 31 | ||||
| Other noncurrent assets | 68 | 94 | 105 | 64 | 55 | 49 | |||
| Other undisclosed noncurrent assets | 5 | 10 | 28 | ||||||
| Total noncurrent assets: | 2,762 | 3,157 | 3,280 | 851 | 843 | 810 | |||
| TOTAL ASSETS: | 4,204 | 4,378 | 4,516 | 1,881 | 1,764 | 1,692 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 455 | 418 | 459 | 201 | 169 | 246 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 1 | 0 | |||
| Accounts payable | 148 | 150 | 216 | 81 | 72 | 129 | |||
| Accrued liabilities | 307 | 268 | 243 | 118 | 97 | 118 | |||
| Deferred revenue | 30 | ||||||||
| Debt | 51 | ||||||||
| Restructuring reserve | 10 | ||||||||
| Liability for uncertainty in income taxes | 2 | ||||||||
| Business combination, contingent consideration, liability | 5 | 26 | |||||||
| Other undisclosed current liabilities | 10 | 59 | 36 | ||||||
| Total current liabilities: | 556 | 482 | 495 | 201 | 195 | 248 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,534 | 1,580 | 1,626 | 34 | 2 | 29 | |||
| Long-term debt, excluding current maturities | 1,532 | 1,578 | 1,624 | ||||||
| Finance lease, liability | 2 | 2 | 2 | 2 | |||||
| Liabilities, other than long-term debt, including: | 67 | 100 | 114 | 22 | 48 | 33 | |||
| Accounts payable and accrued liabilities | 35 | 35 | 42 | 18 | 16 | ||||
| Deferred revenue | 9 | 11 | 16 | 1 | 0 | ||||
| Deferred income tax liabilities | 49 | 56 | 126 | 1 | 2 | ||||
| Liability for uncertainty in income taxes | 14 | ||||||||
| Other liabilities | |||||||||
| Operating lease, liability | 41 | 53 | 61 | 34 | 29 | ||||
| Business combination, contingent consideration, liability | 4 | 26 | 3 | 17 | |||||
| Other undisclosed liabilities, other than long-term debt | (67) | (58) | (156) | 29 | 1 | ||||
| Other undisclosed noncurrent liabilities | 82 | 93 | 192 | 8 | 16 | 5 | |||
| Total noncurrent liabilities: | 1,683 | 1,773 | 1,931 | 64 | 66 | 67 | |||
| Total liabilities: | 2,239 | 2,255 | 2,426 | 265 | 261 | 315 | |||
| Equity | |||||||||
| Equity, attributable to parent | 1,965 | 2,123 | 2,090 | 1,616 | 1,502 | 1,377 | |||
| Common stock | 2 | 2 | 2 | 2 | 2 | 2 | |||
| Treasury stock, value | (0) | (0) | (0) | (0) | (0) | (0) | |||
| Additional paid in capital | 1,412 | 1,366 | 1,331 | 721 | 693 | 669 | |||
| Accumulated other comprehensive loss | (139) | (53) | (81) | (19) | (2) | (15) | |||
| Retained earnings | 690 | 808 | 838 | 912 | 809 | 722 | |||
| Total equity: | 1,965 | 2,123 | 2,090 | 1,616 | 1,502 | 1,377 | |||
| TOTAL LIABILITIES AND EQUITY: | 4,204 | 4,378 | 4,516 | 1,881 | 1,764 | 1,692 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,382 | 2,259 | 2,280 | 1,316 | 1,271 | 1,266 | ||
| Cost of revenue | (1,557) | (1,519) | (1,582) | (825) | (810) | (794) | ||
| Cost of product and service sold | (1,557) | (1,519) | (1,582) | (825) | (810) | (794) | ||
| Gross profit: | 825 | 740 | 698 | 491 | 461 | 472 | ||
| Operating expenses | (782) | (717) | (741) | (368) | (363) | (365) | ||
| Operating income (loss): | 43 | 23 | (43) | 123 | 98 | 107 | ||
| Nonoperating income (expense) | (13) | (6) | (5) | 1 | 1 | 8 | ||
| Investment income, nonoperating | (0) | (0) | (1) | (0) | (0) | |||
| Gain (loss), foreign currency transaction, before tax | (10) | (6) | (6) | (1) | (7) | 1 | ||
| Interest and debt expense | (0) | (103) | (71) | (1) | (2) | (1) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 30 | (86) | (119) | 123 | 97 | 115 | ||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Income (loss) from continuing operations before income taxes: | 30 | (86) | (119) | 123 | 97 | 115 | ||
| Income tax expense (benefit) | (52) | 49 | 40 | (20) | (11) | (14) | ||
| Income (loss) from continuing operations: | (22) | (37) | (79) | 103 | 87 | 101 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 103 | 87 | 101 | |
| Other undisclosed net income | ||||||||
| Net income (loss): | (22) | (37) | (79) | 103 | 87 | 101 | ||
| Other undisclosed net income (loss) attributable to parent | (96) | 8 | 4 | |||||
| Net income (loss) available to common stockholders, diluted: | (118) | (30) | (74) | 103 | 87 | 101 | ||
Comprehensive Income ($ in millions)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (22) | (37) | (79) | 103 | 87 | 101 | ||
| Other comprehensive income (loss) | (86) | 28 | (62) | (18) | 14 | 2 | ||
| Comprehensive income (loss): | (108) | (9) | (140) | 85 | 101 | 103 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (96) | 8 | 4 | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | (204) | (2) | (136) | 85 | 101 | 103 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.